• Daniel Brody, Eat Well’s Co-Founder and Director, has, since June 29, 2022, been buying shares in the company, totaling 8,430,625 as of June 29, 2022
• His purchases highlight his confidence in the company’s current trajectory and its commitment to creating shareholder value
• Eat Well maintains that its revenue guidance for its investee companies still stands at $90 million to $110 million for the 2022 fiscal year

The past year was monumental for Eat Well Investment Group (CSE: EWG) (OTC: EWGFF). Most notably, it marked the company’s market expansion following partnerships with vital retail companies in the United States and Canada, with customers in over 35 countries worldwide. In addition, the period saw the company grow its product offering in a move that aimed to grow its market share and create value for its shareholders.

Going forward, Eat Well’s management has shared its plan to increase its production, specifically of its portfolio company Belle Pulses. Known for producing approximately 90,000 metric tons of protein in 2021, this company now seeks to increase its capacity to nearly 100,000 metric tons annually in Canada, with an additional 15,000 in the U.S (https://ibn.fm/rXUEA).

“Shareholders should know that Belle is increasing its production capacity as it is our goal to help support the global food industry,” noted Mark Coles, Eat Well’s Chief Investment Officer (“CIO”).

“We will continue to expand Belle’s operations and are looking forward to showing the world its ability to procure, process, and deliver proteins to the international marketplace,” he added.

Such moves by Eat Well have elicited confidence from investors and shareholders, the most notable being the company’s Co-Founder and Director, Daniel Brody. Since June 20, 2022, Mr. Brody has been buying more shares in the company, with the most recent completed purchase dating June 29, 2022, equating to over 2,175,000 shares bought this month. Consequently, his shares currently stand at 8,430,625, and it is further projected that he will continue investing in the company (https://ibn.fm/cR2Tn).

The plant-based foods market is projected to account for 7.7% of the global protein market by 2030 at over $162 billion. Bloomberg further notes that plant-based alternatives are here to stay and that consumption will only go up as time progresses. Eat Well understands this opportunity, hence its strategic positioning in the industry. Together, these factors point to the company’s strength and investment potential, as has been evidenced by Daniel Brody’s stock purchases.

For 2022, Eat Well plans to scale up operations further for its portfolio companies. Belle Pulses’ management has projected an improved margin performance, with Amara continuing to bank on its 6,000 distribution points across North American retail to achieve its revenue targets (https://ibn.fm/3ngwj).

To that effect, Eat Well maintains that its revenue guidance for its investee companies still stands at $90 million to $110 million for the 2022 fiscal year. Additionally, the company has cited that its bottom-line profitability of combined investments is projected to improve throughout the calendar year, showing how much value the company is creating for its shareholders and why it is worth investing in.

For more information, visit the company’s website at www.EatWellGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.